NCT04381897View on ClinicalTrials.gov

Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2027

Conditions
Cornelia de Lange Syndrome
Interventions
DRUG

N-acetyl cysteine

Oral solution for N-acetyl cysteine is prepared in syringes and provided to the participants along with instructions on how to administer them.

OTHER

Placebo

NAC Placebo-matching solution is prepared in syringes and provided to the participants along with instructions on how to administer them.

Trial Locations (1)

21205

Johns Hopkins University School of Medicine, Baltimore

All Listed Sponsors
collaborator

Cornelia de Lange Syndrome Foundation

UNKNOWN

lead

Johns Hopkins University

OTHER